A number of different scales were used (MLWHF, EQ-5D and SF-36). The effect estimates were based on single studies and ranged from showing a clinically important improvement in QoL to no clinical difference. A single study (n=287) reported the outcome adherence to intervention. This evidence was very low quality and showed no clinical effect. Community This strata included studies with populations comprising of people who were recruited within the community. For the outcome all-cause mortality, 9 studies (n=4495) were included. The quality of the evidence was low and did not demonstrate a clear effect with the confidence interval ranging from a decrease and increase in all-cause mortality.The outcome all-cause hospitalisations contained 6 studies (n=2694), was rated low quality and showed a clinically important reduction in hospitalisations. For the outcome QoL the quality of the evidence ranged from high to very low quality depending on the scale being used. High quality evidence was obtained for 4 studies (n=2103) using the MLWHF score which showed no clinically important effect. For the scores (HDS and HFSS) there was a clinically important improvement in QoL and no clinical effect observed respectively. Mixed This strata included studies which did not specify which population were included. They therefore potentially represent a mixture of both people who have had a recent admission to hospital and those who were recruited within the community. For the outcome all-cause mortality, 1 study was included (n=254). The quality of the evidence was very low and did not demonstrate a clear effect with the confidence interval ranging from a decrease and increase in all-cause mortality.The outcome all-cause hospitalisations contained the same study and was rated low quality, and also showed a clinically important increase in hospitalisations (again associated with wide confidence). 